Assignee
BLOODWORKS
US·21 granted patents·13 pending applications·21 citations·filing 2013–2024
Top patents by PatentIndex Score
34 records- 0194US9903876B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2017·Granted Feb 27, 2018·9 cites·12 claims
- 0286US10253109B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2015·Granted Apr 9, 2019·3 cites·15 claims
- 0385US11248060B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2019·Granted Feb 15, 2022·2 cites·18 claims
- 0484US2025011467A1Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2024·Application pending·0 cites
- 0583US10830777B2Biochemical predictors of red blood cell qualityBLOODWORKS·Filed 2016·Granted Nov 10, 2020·2 cites·8 claims
- 0683US10578627B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2019·Granted Mar 3, 2020·1 cites·9 claims
- 0782US10345316B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2018·Granted Jul 9, 2019·1 cites·10 claims
- 0879US10705093B2Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stressBLOODWORKS·Filed 2015·Granted Jul 7, 2020·3 cites·20 claims
- 0977US12030956B2Antibodies that recognize red blood cell antigensBLOODWORKS·Filed 2022·Granted Jul 9, 2024·0 cites·13 claims
- 1071US11047868B2Biochemical markers of red blood cell storage and toxicityBLOODWORKS·Filed 2020·Granted Jun 29, 2021·0 cites·9 claims
- 1168US12584929B2Composition and methods for assessing sensitivity and specificity of antibody detection reagentsBLOODWORKS·Filed 2021·Granted Mar 24, 2026·0 cites·10 claims
- 1267US11892458B2Biochemical predictors of red blood cell qualityBLOODWORKS·Filed 2020·Granted Feb 6, 2024·0 cites·12 claims
- 1366US11693018B2Dicarboxylic acids and correlated compounds as a measure of red blood cell qualityBLOODWORKS·Filed 2020·Granted Jul 4, 2023·0 cites·15 claims
- 1466US10330668B2Biochemical markers of platelet storageBLOODWORKS·Filed 2014·Granted Jun 25, 2019·0 cites·12 claims
- 1564US2021308239A1Therapeutic induction of tolerance using recombinant cell surface antigensBLOODWORKS·Filed 2021·Application pending·0 cites
- 1661US10806695B2Protein stabilizing factorsBLOODWORKS·Filed 2019·Granted Oct 20, 2020·0 cites·19 claims
- 1760US11085937B2Composition and methods for assessing sensitivity and specificity of antibody detection reagentsBLOODWORKS·Filed 2016·Granted Aug 10, 2021·0 cites·13 claims
- 1860US2019265228A1Biochemical markers of platelet storageBLOODWORKS·Filed 2019·Application pending·0 cites
- 1958US10677781B2STEAP3 as a biochemical marker of red blood cell storage and toxicityBLOODWORKS·Filed 2019·Granted Jun 9, 2020·0 cites·10 claims
- 2058US10441531B2Protein stabilizing factorsBLOODWORKS·Filed 2013·Granted Oct 15, 2019·0 cites·25 claims
- 2154US10816557B2Dicarboxylic acids and correlated compounds as a measure of red blood cell qualityBLOODWORKS·Filed 2015·Granted Oct 27, 2020·0 cites·8 claims
- 2253US2019117694A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2018·Application pending·0 cites
- 2351US2020319199A1Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stressBLOODWORKS·Filed 2020·Application pending·0 cites
- 2449US10785967B2Mice with a modified glucose-6-phosphate dehydrogenase geneBLOODWORKS·Filed 2016·Granted Sep 29, 2020·0 cites·10 claims
- 2549US2019046620A1Therapeutic induction of tolerance using recombinant cell surface antigensBLOODWORKS·Filed 2017·Application pending·0 cites
- 2648US2020060262A1Methods to reduce clot formation in cold-stored platelet productsBLOODWORKS·Filed 2019·Application pending·0 cites
- 2747US10274480B2Steap3 as a biochemical marker of red blood cell storage and toxicityBLOODWORKS·Filed 2015·Granted Apr 30, 2019·0 cites·12 claims
- 2845US2021041463A1Antibody screens using transgenic antigen(s)BLOODWORKS·Filed 2019·Application pending·0 cites
- 2944US2017202963A1Methods of Preventing Platelet Alloimmunization and Alloimmune Platelet Refractoriness and Induction of Tolerance in Transfused RecipientsBLOODWORKS·Filed 2015·Application pending·0 cites
- 3042US2017261489A1Antibody response phenotypingBLOODWORKS·Filed 2017·Application pending·0 cites
- 3138US2020132700A1Methods of predicting post-transfusion survival of red blood cellsBLOODWORKS·Filed 2017·Application pending·0 cites
- 3238US2020138950A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2017·Application pending·0 cites
- 3337US11181534B2Routine laboratory and point-of-care (POC) testing for hemostasisBLOODWORKS·Filed 2015·Granted Nov 23, 2021·0 cites·22 claims
- 3431US2016271179A1Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipientsBLOODWORKS·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →